{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for methylphenidate in Display Name (approximate match)
Showing 1 - 5 of 5 results
Status:
US Approved Rx
(2018)
Source:
ANDA210139
(2018)
Source URL:
First approved in 1955
Source:
NDA010187
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Methylphenidate is a CNS stimulant approved for the treatment of narcolepsy and attention deficit hyperactivity disorder. The drug is believed to bind the dopamine transporter in the presynaptic cell membrane, thereby blocking the reuptake of dopamine and causing an increase in extracellular dopamine levels.
Status:
US Approved Rx
(2018)
Source:
ANDA210139
(2018)
Source URL:
First approved in 1955
Source:
NDA010187
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Methylphenidate is a CNS stimulant approved for the treatment of narcolepsy and attention deficit hyperactivity disorder. The drug is believed to bind the dopamine transporter in the presynaptic cell membrane, thereby blocking the reuptake of dopamine and causing an increase in extracellular dopamine levels.
Status:
US Approved Rx
(2018)
Source:
ANDA210139
(2018)
Source URL:
First approved in 1955
Source:
NDA010187
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Methylphenidate is a CNS stimulant approved for the treatment of narcolepsy and attention deficit hyperactivity disorder. The drug is believed to bind the dopamine transporter in the presynaptic cell membrane, thereby blocking the reuptake of dopamine and causing an increase in extracellular dopamine levels.
